Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability

INTRODUCTION: To demonstrate efficacy and safety of an ophthalmic hydrogel formulation of netilmicin/dexamethasone, containing xanthan gum twice a day (b.i.d.) versus netilmicin/dexamethasone eye drops four times a day (q.i.d) to treat inflammation and prevention of infection after cataract surgery....

Descripción completa

Detalles Bibliográficos
Autores principales: Mencucci, Rita, Ach, Thomas, Liekfeld, Anja, Scialdone, Antonio, Civiale, Claudine, Mazzone, Maria Grazia, Caporossi, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618540/
https://www.ncbi.nlm.nih.gov/pubmed/36203046
http://dx.doi.org/10.1007/s12325-022-02295-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618540/
https://www.ncbi.nlm.nih.gov/pubmed/36203046
http://dx.doi.org/10.1007/s12325-022-02295-y

Ejemplares similares